Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-30 @ 10:11 AM
Study NCT ID:
NCT01263834
Status:
COMPLETED
Last Update Posted:
2014-01-31
First Post:
2010-12-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome
Sponsor:
Prince of Songkla University
Organization:
Study Overview
Official Title:
The Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome: A Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Bevacizumab
Brief Summary:
The purpose of this study is to evaluate the adjunctive effect of intratenon Bevacizumab on the result of trabeculectomy in primary term of intraocular pressure (IOP).
Detailed Description:
Prospective interventional clinical trial
Single center, outcome assessor-masked, active control, randomized controlled trial
Single center, outcome assessor-masked, active control, randomized controlled trial
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: